Efficient intrathymic gene transfer following in situ administration of a rAAV serotype 8 vector in mice and nonhuman primates

Molecular Therapy

Volumn 17, Issue 3, 2009, Pages 472-479

  Moreau, Aurélie ^a   Vicente, Rita ^b,c   Dubreil, Laurence ^d   Adjali, Oumeya ^a,b   Podevin, Guillaume ^a   Jacquet, Chantal ^b   Deschamps, Jack Yves ^d   Klatzmann, David ^e   Cherel, Yan ^d   Taylor, Naomi ^b   Moullier, Philippe ^a,f   Zimmermann, Valérie S ^b  

^a HÔTEL DIEU   (France)

^b CNRS   (France)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d LUNAM UNIVERSITÉ   (France)

^e SORBONNE UNIVERSITÉ   (France)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS ASSOCIATED VIRUS VECTOR; ADENOVIRUS VECTOR; CAPSID PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; IN VIVO GENE TRANSFER; INTRATHYMIC DRUG ADMINISTRATION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; MACACA; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; SEROTYPE; T LYMPHOCYTE; THYMUS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT;

ADENO-ASSOCIATED VIRUS; ANIMALIA; MACACA; MIRIDAE; MURINAE; MUS; PRIMATES;

EID: 61649110445     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.272     Document Type: Article

References (48)

1. Porritt, HE, Gordon, K and Petrie, HT (2003). Kinetics of steady-state differentiation and mapping of intrathymic-signaling environments by stem cell transplantation in nonirradiated mice. J Exp Med 198 957-962.
2. Rodewald, HR (2008). Thymus organogenesis. Annu Rev Immunol 26 355-388.
3. Khoury, SJ, Sayegh, MH, Hancock, WW, Gallon, L, Carpenter, CB and Weiner, HL (1993). Acquired tolerance to experimental autoimmune encephalomyelitis by intrathymic injection of myelin basic protein or its major encephalitogenic peptide. J Exp Med 178: 559-566.
4. DeMatteo, RP, Chu, G, Ahn, M, Chang, E, Barker, CF and Markmann, JF (1997). Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J Virol 71: 5330-5335.
5. Marodon, G, Fisson, S, Levacher, B, Fabre, M, Salomon, BL and Klatzmann, D (2006). Induction of antigen-specific tolerance by intrathymic injection of lentiviral vectors. Blood 108: 2972-2978.
6. Posselt, AM, Barker, CF, Friedman, AL and Naji, A (1992). Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science 256: 1321-1324.
7. Adjali, O, Marodon, G, Steinberg, M, Mongellaz, C, Thomas-Vaslin, V, Jacquet, C et al. (2005). In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer. J Clin Invest 115: 2287-2295.
8. Le Bec, C and Douar, AM (2006). Gene therapy progress and prospects - vectorology: Design and production of expression cassettes in AAV vectors. Gene Ther 13: 805-813.
9. Russell, DW (2007). AAV vectors, insertional mutagenesis, and cancer. Mol Ther 15: 1740-1743.
10. Kaplitt, MG, Leone, P, Samulski, RJ, Xiao, X, Pfaff, DW, O'Malley, KL et al. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8: 148-154.
11. Kaplitt, MG, Xiao, X, Samulski, RJ, Li, J, Ojaama, K Klein, IL et al. (1996). Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann Thorac Surg 62: 1669-1676.
12. McCown, TJ, Xiao, X, Li, J, Breese, GR and Samulski, RJ (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 713: 99-107.
13. Griffey, MA, Wozniak, D, Wong, M, Bible, E, Johnson, K, Rothman, SM et al. (2006). CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Mol Ther 13: 538-547.
14. Sondhi, D, Peterson, DA, Giannaris, EL, Sanders, CT, Mendez, BS, De, B et al. (2005). AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCL. Gene Ther 12: 1618-1632.
15. Xiao, X, Li, J, McCown, TJ and Samulski, RJ (1997). Gene transfer by adeno-associated virus vectors into the central nervous system. Exp Neurol 144: 113-124.
16. Hargrove, PW, Vanin, EF, Kurtzman, GJ and Nienhuis, AW (1997). High-level globin gene expression mediated by a recombinant adeno-associated virus genome that contains the 3' gamma globin gene regulatory element and integrates as tandem copies in erythroid cells. Blood 89: 2167-2175.
17. Malik, P, McQuiston, SA, Yu, XJ, Pepper, KA, Krall, WJ, Podsakoff, GM et al. (1997). Recombinant adeno-associated virus mediates a high level of gene transfer but less efficient integration in the K562 human hematopoietic cell line. J Virol 71: 1776-1783.
18. Nathwani, AC, Hanawa, H, Vandergriff, J, Kelly, P, Vanin, EF and Nienhuis, AW (2000). Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38-subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV. Gene Ther 7: 183-195.
19. Choi, VW, McCarty, DM and Samulski, RJ (2005). AAV hybrid serotypes: improved vectors for gene delivery. Curr Gene Ther 5: 299-310.
20. Gao, G, Vandenberghe, LH and Wilson, JM (2005). New recombinant serotypes of AAV vectors. Curr Gene Ther 5: 285-297.
21. Rabinowitz, JE, Rolling, F, Li, C, Conrath, H, Xiao, W, Xiao, X et al. (2002). Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 76: 791-801.
22. Grimm, D and Kay, MA (2003). From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy. Curr Gene Ther 3: 281-304.
23. Zhong, L, Li, W, Li, Y, Zhao, W, Wu, J, Li, B et al. (2006). Evaluation of primitive murine hematopoietic stem and progenitor cell transduction in vitro and in vivo by recombinant adeno-associated virus vector serotypes 1 through 5. Hum Gene Ther 17: 321-333.
24. Fisher, KJ, Kelley, WM, Burda, JF and Wilson, JM (1996). A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome. Hum Gene Ther 7: 2079-2087.
25. Nathwani, AC, Gray, JT, Ng, CY, Zhou, J, Spence, Y, Waddington, SN et al. (2006). Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver. Blood 107: 2653-2661.
26. McCarty, DM, Fu, H, Monahan, PE, Toulson, CE, Naik, P and Samulski, RJ (2003). Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther 10: 2112-2118.
27. Wang, Z, Ma, HI, Li, J, Sun, L, Zhang, J and Xiao, X (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther 10: 2105-2111.
28. Hirata, RK and Russell, DW (2000). Design and packaging of adeno-associated virus gene targeting vectors. J Virol 74: 4612-4620.
29. Yang, GS, Schmidt, M, Yan, Z, Lindbloom, JD, Harding, TC, Donahue, BA et al. (2002). Virus-mediated transduction of murine retina with adeno-associated virus: Effects of viral capsid and genome size. J Virol 76: 7651-7660.
30. Maina, N, Han, Z, Li, X, Hu, Z, Zhong, L, Bischof, D et al. (2008). Recombinant self-complementary adeno-associated virus serotype vector-mediated hematopoietic stem cell transduction and lineage-restricted, long-term transgene expression in a murine serial bone marrow transplantation model. Hum Gene Ther 19: 376-383.
31. Weerkamp, F, de Haas, EF, Naber, BA, Comans-Bitter, WM, Bogers, AJ, van Dongen, JJ et al. (2005). Age-related changes in the cellular composition of the thymus in children. J Allergy Clin Immunol 115: 834-840.
32. Gao, GP, Alvira, MR, Wang, L, Calcedo, R, Johnston, J and Wilson, JM (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 99: 11854-11859.
33. Wang, Z, Zhu, T, Qiao, C, Zhou, L, Wang, B, Zhang, J et al. (2005). Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol 23: 321-328.
34. Han, Z, Zhong, L, Maina, N, Hu, Z, Li, X, Chouthai, NS et al. (2008). Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells. Hum Gene Ther 19: 267-278.
35. Zincarelli, C, Soltys, S, Rengo, G and Rabinowitz, JE (2008). Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 16: 1073-1080.
36. Egerton, M, Scollay, R and Shortman, K (1990). Kinetics of mature T-cell development in the thymus. Proc Natl Acad Sci USA 87: 2579-2582.
37. Thomas-Vaslin, V, Altes, HK, de Boer, RJ and Klatzmann, D (2008). Comprehensive assessment and mathematical modeling of T cell population dynamics and homeostasis. J Immunol 180: 2240-2250.
38. Marodon, G and Klatzmann, D (2004). In situ transduction of stromal cells and thymocytes upon intrathymic injection of lentiviral vectors. BMC Immunol 5: 18.
39. DeMatteo, RP, Raper, SE, Ahn, M, Fisher, KJ, Burke, C, Radu, A et al. (1995). Gene transfer to the thymus. A means of abrogating the immune response to recombinant adenovirus. Ann Surg 222: 229-239; discussion 239-242.
40. Berzins, SP, Godfrey, DI, Miller, JF and Boyd, RL (1999). A central role for thymic emigrants in peripheral T cell homeostasis. Proc Natl Acad Sci USA 96: 9787-9791.
41. Almeida, AR, Rocha, B, Freitas, AA and Tanchot, C (2005). Homeostasis of T cell numbers: From thymus production to peripheral compartmentalization and the indexation of regulatory T cells. Semin Immunol 17: 239-249.
42. Favre, D, Blouin, V, Provost, N, Spisek, R, Porrot, F, Bohl, D et al. (2002). Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol 76: 11605-11611.
43. Zaiss, AK and Muruve, DA (2008). Immunity to adeno-associated virus vectors in animals and humans: A continued challenge. Gene Ther 15: 808-816.
44. Tian, C, Bagley, J and Iacomini, J (2007). Homeostatic expansion permits T cells to re-enter the thymus and deliver antigen in a tolerogenic fashion. Am J Transplant 7: 1934-1941.
45. Tian, C, Bagley, J, Forman, D and Iacomini, J (2004). Induction of central tolerance by mature T cells. J Immunol 173: 7217-7222.
46. Grimm, D, Kay, MA and Kleinschmidt, JA (2003). Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol Ther 7 839-850.
47. Chenuaud, P, Larcher, T, Rabinovitz, JE, Provost, N, Joussemet, B, Bujard, H et al. (2004). Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle. Mol Ther 9: 410-418.
48. Salvetti, A, Oreve, S, Chadeuf, G, Favre, D, Cherel, Y, Champion-Arnaud, P et al. (1998). Factors influencing recombinant adeno-associated virus production. Hum Gene Ther 9: 695-706.